Novel Therapies for Neovascular Retinal Disease - Expert Analysis of New Key Data

Commentary
Podcast

In this PER On Air Ophthalmology Times Podcast, a panel of experts takes a closer look at newer-generation anti-VEGF agents for the treatment of nAMD and DME, sharing insights into clinical trial and real-world data, patient education, and other important considerations for treatment.

In this PER On Air Ophthalmology Times Podcast, a panel of experts takes a closer look at newer-generation anti-VEGF agents for the treatment of nAMD and DME, sharing insights into clinical trial and real-world data, patient education, and other important considerations for treatment.

Faculty:

Roger A. Goldberg, MD, MBA

Vitreoretinal Specialist

Bay Area Retina Associates

Volunteer Faculty

California Pacific Medical Center

Walnut Creek, CA

David R.P. Almeida, MD, PhD, MBA

President and CEO

Erie Retina Research

Center for Advanced Surgical Exploration

Erie, PA

Jennifer I. Lim, MD, FARVO

Marion H. Schenk Esq. Chair in Ophthalmology for Research of the Aging Eye

UIC Distinguished Professor of Ophthalmology

Director, Retina Service

Vice-Chair, Diversity and Inclusion

University of Illinois at Chicago

Chicago, IL

Related Videos
This series features 1 KOL.
This series features 1 KOL.
This series features 1 KOL.
Alice Epitropoulos, MD, and Laura M. Periman, MD
Alice Epitropoulos, MD, and Laura M. Periman, MD
© 2024 MJH Life Sciences

All rights reserved.